Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Pain | 37 | 2024 | 86 | 8.350 |
Why?
|
| Dysmenorrhea | 28 | 2025 | 59 | 7.800 |
Why?
|
| Chronic Pain | 20 | 2024 | 185 | 4.920 |
Why?
|
| Cystitis, Interstitial | 12 | 2024 | 55 | 3.950 |
Why?
|
| Endometriosis | 7 | 2022 | 63 | 2.790 |
Why?
|
| Pain Measurement | 21 | 2025 | 373 | 2.600 |
Why?
|
| Dyspareunia | 5 | 2025 | 23 | 2.350 |
Why?
|
| Pain Threshold | 14 | 2025 | 63 | 2.280 |
Why?
|
| Urinary Bladder | 8 | 2025 | 260 | 2.110 |
Why?
|
| Laparoscopy | 14 | 2022 | 782 | 1.960 |
Why?
|
| Pelvic Floor | 6 | 2022 | 88 | 1.250 |
Why?
|
| Irritable Bowel Syndrome | 5 | 2023 | 46 | 1.150 |
Why?
|
| Female | 70 | 2025 | 48702 | 1.140 |
Why?
|
| Visceral Pain | 2 | 2018 | 6 | 1.080 |
Why?
|
| Musculoskeletal Diseases | 5 | 2011 | 36 | 1.080 |
Why?
|
| Pain | 4 | 2025 | 414 | 0.940 |
Why?
|
| Hyperalgesia | 2 | 2017 | 22 | 0.920 |
Why?
|
| Gynecologic Surgical Procedures | 4 | 2021 | 163 | 0.900 |
Why?
|
| Physical Examination | 4 | 2015 | 144 | 0.820 |
Why?
|
| Humans | 74 | 2025 | 93515 | 0.820 |
Why?
|
| Pelvis | 2 | 2021 | 100 | 0.810 |
Why?
|
| Uterus | 5 | 2018 | 227 | 0.770 |
Why?
|
| Cross-Sectional Studies | 16 | 2023 | 1847 | 0.760 |
Why?
|
| Uterine Myomectomy | 3 | 2017 | 10 | 0.750 |
Why?
|
| Gastroenterologists | 1 | 2022 | 31 | 0.690 |
Why?
|
| Young Adult | 18 | 2025 | 6930 | 0.680 |
Why?
|
| Hysterectomy | 4 | 2022 | 167 | 0.640 |
Why?
|
| Adult | 34 | 2025 | 27918 | 0.640 |
Why?
|
| Dysuria | 1 | 2019 | 7 | 0.620 |
Why?
|
| Hemostasis, Surgical | 2 | 2017 | 23 | 0.620 |
Why?
|
| Prospective Studies | 10 | 2025 | 4560 | 0.620 |
Why?
|
| Simulation Training | 1 | 2021 | 107 | 0.610 |
Why?
|
| Menstruation | 5 | 2025 | 35 | 0.590 |
Why?
|
| Constipation | 1 | 2019 | 66 | 0.590 |
Why?
|
| Naproxen | 4 | 2024 | 15 | 0.570 |
Why?
|
| Autonomic Nervous System | 1 | 2019 | 67 | 0.560 |
Why?
|
| Prostatitis | 3 | 2024 | 14 | 0.540 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2017 | 18 | 0.520 |
Why?
|
| Uterine Contraction | 1 | 2017 | 8 | 0.520 |
Why?
|
| Platelet Activating Factor | 1 | 2017 | 53 | 0.520 |
Why?
|
| Episiotomy | 1 | 2016 | 3 | 0.510 |
Why?
|
| Uterine Diseases | 1 | 2016 | 19 | 0.500 |
Why?
|
| Surveys and Questionnaires | 10 | 2025 | 2802 | 0.500 |
Why?
|
| Vagina | 2 | 2008 | 177 | 0.490 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 163 | 0.470 |
Why?
|
| Nociceptive Pain | 1 | 2015 | 3 | 0.460 |
Why?
|
| Contraceptives, Oral, Hormonal | 2 | 2017 | 18 | 0.450 |
Why?
|
| Chronic Disease | 7 | 2022 | 960 | 0.430 |
Why?
|
| Adolescent | 11 | 2025 | 9606 | 0.420 |
Why?
|
| Parity | 1 | 2014 | 97 | 0.410 |
Why?
|
| Motor Cortex | 1 | 2016 | 209 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2025 | 249 | 0.400 |
Why?
|
| Ultrasonography | 2 | 2013 | 702 | 0.380 |
Why?
|
| Hypoxia | 1 | 2017 | 675 | 0.360 |
Why?
|
| Case-Control Studies | 7 | 2025 | 1931 | 0.360 |
Why?
|
| Depression | 3 | 2025 | 544 | 0.350 |
Why?
|
| Neuralgia | 1 | 2011 | 27 | 0.340 |
Why?
|
| Analgesia | 1 | 2011 | 64 | 0.320 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 29 | 0.320 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2009 | 15 | 0.310 |
Why?
|
| Anxiety | 2 | 2025 | 337 | 0.300 |
Why?
|
| Hysteroscopy | 1 | 2008 | 6 | 0.290 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 115 | 0.290 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 283 | 0.280 |
Why?
|
| Miniaturization | 1 | 2007 | 12 | 0.270 |
Why?
|
| Oxytocin | 2 | 2020 | 75 | 0.270 |
Why?
|
| Laparoscopes | 1 | 2007 | 15 | 0.270 |
Why?
|
| Ambulatory Care | 1 | 2008 | 193 | 0.260 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 92 | 0.260 |
Why?
|
| Comorbidity | 2 | 2022 | 1007 | 0.260 |
Why?
|
| Vasopressins | 2 | 2017 | 50 | 0.250 |
Why?
|
| Gynecology | 3 | 2019 | 130 | 0.250 |
Why?
|
| Pressure | 3 | 2017 | 166 | 0.250 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1917 | 0.230 |
Why?
|
| Analgesics | 3 | 2020 | 127 | 0.230 |
Why?
|
| Middle Aged | 15 | 2019 | 27573 | 0.230 |
Why?
|
| Biomarkers | 2 | 2025 | 1910 | 0.230 |
Why?
|
| Eicosanoids | 1 | 2025 | 17 | 0.230 |
Why?
|
| Oxylipins | 1 | 2025 | 18 | 0.230 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 1922 | 0.230 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2715 | 0.220 |
Why?
|
| Benchmarking | 1 | 2005 | 80 | 0.220 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 81 | 0.220 |
Why?
|
| Peritoneal Diseases | 1 | 2005 | 15 | 0.220 |
Why?
|
| Risk Factors | 5 | 2025 | 5899 | 0.220 |
Why?
|
| Abdominal Pain | 1 | 2006 | 143 | 0.220 |
Why?
|
| Tissue Adhesions | 1 | 2005 | 53 | 0.220 |
Why?
|
| Menarche | 1 | 2024 | 30 | 0.200 |
Why?
|
| Endometrium | 1 | 2024 | 51 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 985 | 0.190 |
Why?
|
| Pilot Projects | 5 | 2020 | 917 | 0.190 |
Why?
|
| Dinoprost | 2 | 2025 | 27 | 0.190 |
Why?
|
| Consensus | 2 | 2021 | 368 | 0.180 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2014 | 624 | 0.180 |
Why?
|
| Self Report | 2 | 2014 | 328 | 0.170 |
Why?
|
| Syndrome | 3 | 2024 | 437 | 0.170 |
Why?
|
| Electroencephalography | 1 | 2025 | 797 | 0.160 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 356 | 0.150 |
Why?
|
| Inflammation | 1 | 2025 | 1050 | 0.150 |
Why?
|
| Varicose Veins | 1 | 2019 | 9 | 0.150 |
Why?
|
| Vulva | 1 | 2019 | 23 | 0.150 |
Why?
|
| Urination | 1 | 2019 | 39 | 0.150 |
Why?
|
| Oxygen | 1 | 2024 | 769 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 920 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3476 | 0.140 |
Why?
|
| Collagenases | 1 | 1998 | 42 | 0.140 |
Why?
|
| Pain, Referred | 1 | 2018 | 2 | 0.140 |
Why?
|
| Abdominal Muscles | 1 | 2018 | 23 | 0.140 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2018 | 5 | 0.140 |
Why?
|
| Muscle Cramp | 1 | 2018 | 4 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2019 | 99 | 0.140 |
Why?
|
| Obstetric Labor, Premature | 1 | 1998 | 58 | 0.140 |
Why?
|
| Phenotype | 3 | 2022 | 2544 | 0.130 |
Why?
|
| Muscle Contraction | 1 | 2018 | 256 | 0.130 |
Why?
|
| Leiomyoma | 3 | 2017 | 211 | 0.130 |
Why?
|
| Diuresis | 1 | 2017 | 26 | 0.130 |
Why?
|
| Pregnancy | 3 | 2014 | 3147 | 0.130 |
Why?
|
| Biomedical Research | 2 | 2019 | 438 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2017 | 233 | 0.130 |
Why?
|
| Uterine Neoplasms | 3 | 2017 | 277 | 0.120 |
Why?
|
| Perineum | 1 | 2016 | 37 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 5410 | 0.120 |
Why?
|
| Heart Rate | 1 | 2019 | 505 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 302 | 0.120 |
Why?
|
| Hemostatics | 1 | 2016 | 60 | 0.120 |
Why?
|
| Perfusion | 1 | 2017 | 260 | 0.120 |
Why?
|
| Illinois | 2 | 2009 | 520 | 0.120 |
Why?
|
| Palpation | 1 | 2015 | 19 | 0.120 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 131 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2017 | 579 | 0.110 |
Why?
|
| Symptom Assessment | 1 | 2015 | 71 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2016 | 218 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 191 | 0.110 |
Why?
|
| Pelvic Floor Disorders | 1 | 2015 | 57 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2019 | 896 | 0.110 |
Why?
|
| Pain Management | 1 | 2016 | 180 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2009 | 1006 | 0.110 |
Why?
|
| Male | 6 | 2025 | 44557 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 1053 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1723 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 283 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2016 | 276 | 0.100 |
Why?
|
| Research Design | 1 | 2018 | 617 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2016 | 322 | 0.100 |
Why?
|
| Australia | 1 | 2014 | 123 | 0.100 |
Why?
|
| Fertility | 1 | 2014 | 119 | 0.100 |
Why?
|
| Prevalence | 2 | 2008 | 1321 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2016 | 569 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1713 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2121 | 0.090 |
Why?
|
| Nerve Net | 1 | 2016 | 394 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 889 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2011 | 159 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2011 | 38 | 0.080 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.080 |
Why?
|
| Animals | 4 | 2021 | 28155 | 0.080 |
Why?
|
| Child | 1 | 2022 | 7355 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1161 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 391 | 0.080 |
Why?
|
| Databases as Topic | 1 | 2010 | 96 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 157 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 626 | 0.070 |
Why?
|
| Surgicenters | 1 | 2008 | 5 | 0.070 |
Why?
|
| Vulvar Vestibulitis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Internet | 1 | 2010 | 337 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 62 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1546 | 0.060 |
Why?
|
| Quality of Life | 3 | 2022 | 1780 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2024 | 3054 | 0.060 |
Why?
|
| Healthcare Common Procedure Coding System | 1 | 2005 | 1 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2025 | 44 | 0.060 |
Why?
|
| Dinoprostone | 1 | 2025 | 71 | 0.060 |
Why?
|
| Brain | 1 | 2016 | 2391 | 0.060 |
Why?
|
| Mice | 3 | 2017 | 12269 | 0.060 |
Why?
|
| North Carolina | 1 | 2005 | 56 | 0.050 |
Why?
|
| Organ Size | 1 | 2005 | 362 | 0.050 |
Why?
|
| United States | 2 | 2008 | 7622 | 0.050 |
Why?
|
| Uterine Artery | 1 | 2024 | 6 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2010 | 10164 | 0.050 |
Why?
|
| Obstetrics | 1 | 2005 | 123 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2024 | 76 | 0.050 |
Why?
|
| Myometrium | 1 | 2024 | 54 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2001 | 172 | 0.050 |
Why?
|
| Thymus Gland | 2 | 2001 | 196 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2005 | 406 | 0.050 |
Why?
|
| Myalgia | 1 | 2022 | 7 | 0.050 |
Why?
|
| Goals | 1 | 2022 | 67 | 0.040 |
Why?
|
| Aged | 3 | 2015 | 20434 | 0.040 |
Why?
|
| Isoantigens | 1 | 2001 | 72 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1103 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 207 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 186 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2018 | 38 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 83 | 0.030 |
Why?
|
| Pain Perception | 1 | 2018 | 19 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 1997 | 23 | 0.030 |
Why?
|
| Antilymphocyte Serum | 1 | 1997 | 67 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 2017 | 17 | 0.030 |
Why?
|
| Receptors, Oxytocin | 1 | 2017 | 10 | 0.030 |
Why?
|
| Sildenafil Citrate | 1 | 2017 | 24 | 0.030 |
Why?
|
| Clonal Anergy | 1 | 1997 | 32 | 0.030 |
Why?
|
| Denervation | 1 | 2017 | 25 | 0.030 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 1 | 2017 | 27 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 29 | 0.030 |
Why?
|
| Electromyography | 1 | 2018 | 198 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 2562 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2013 | 756 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 1997 | 83 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2017 | 118 | 0.030 |
Why?
|
| Pharmacogenomic Variants | 1 | 2017 | 45 | 0.030 |
Why?
|
| Ketorolac | 1 | 2016 | 6 | 0.030 |
Why?
|
| Ablation Techniques | 1 | 2017 | 43 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2017 | 99 | 0.030 |
Why?
|
| Epitopes | 1 | 1997 | 254 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 2017 | 53 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 133 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1729 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 145 | 0.030 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2016 | 30 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 240 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 61 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2005 | 1090 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2017 | 122 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2016 | 127 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 312 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2001 | 1120 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 811 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2001 | 1275 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 337 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 1997 | 295 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2015 | 298 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 513 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3911 | 0.020 |
Why?
|
| Search Engine | 1 | 2010 | 11 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 124 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2001 | 1101 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 2441 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2010 | 621 | 0.020 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2005 | 2 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7061 | 0.010 |
Why?
|
| Pain, Intractable | 1 | 2004 | 8 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 9099 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 3435 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 244 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2001 | 143 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2001 | 1014 | 0.010 |
Why?
|
| Injections, Intralymphatic | 1 | 1997 | 1 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 102 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 113 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1997 | 369 | 0.010 |
Why?
|
| Spleen | 1 | 1997 | 374 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1997 | 191 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1997 | 375 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 797 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 481 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1997 | 1587 | 0.010 |
Why?
|
| Graft Survival | 1 | 1997 | 937 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1997 | 660 | 0.010 |
Why?
|